• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血因子VIII与人类血小板聚集。I. 牛凝血因子VIII的血小板聚集活性是其“载体蛋白”亚基特性的证据。

Factor VIII and human platelet aggregation. I. Evience that the platelet aggregating activity of bovine factor VIII is a property of its 'carrier protein' subunit.

作者信息

Bottecchia D, Vermylen J

出版信息

Br J Haematol. 1976 Oct;34(2):303-11. doi: 10.1111/j.1365-2141.1976.tb00200.x.

DOI:10.1111/j.1365-2141.1976.tb00200.x
PMID:987796
Abstract

Bovine factor VIII is a potent inducer of aggregation of human platelets. Upon gel filtration of five-thousand-fold purified material in 0.5 M CaCl2, bovine factor VIII is separated into high and low molecular weight components; the former contains both a 'carrier protein' and platelet aggregating activity, the latter the procoagulant activity (low molecular weight factor VII, LMW-FVIII). Upon removal of Ca2+ ions, LMW-F VIII recombines with the 'carrier protein'. LMW-F VIII modifies aggregation by 'carrier protein', but not aggregation by undissociated bovine factor VII, adenosine-5'-diphosphate or adrenaline. This finding indicates that the platelet aggregating activity in indeed a property of the 'carrier protein'.

摘要

牛因子VIII是人类血小板聚集的强效诱导剂。在0.5M氯化钙中对经过五千倍纯化的物质进行凝胶过滤时,牛因子VIII被分离为高分子量和低分子量组分;前者同时含有一种“载体蛋白”和血小板聚集活性,后者含有促凝血活性(低分子量因子VIII,LMW-FVIII)。去除钙离子后,LMW-FVIII与“载体蛋白”重新结合。LMW-FVIII通过“载体蛋白”改变聚集,但不改变未解离的牛因子VIII、腺苷-5'-二磷酸或肾上腺素所引起的聚集。这一发现表明血小板聚集活性确实是“载体蛋白”的一种特性。

相似文献

1
Factor VIII and human platelet aggregation. I. Evience that the platelet aggregating activity of bovine factor VIII is a property of its 'carrier protein' subunit.凝血因子VIII与人类血小板聚集。I. 牛凝血因子VIII的血小板聚集活性是其“载体蛋白”亚基特性的证据。
Br J Haematol. 1976 Oct;34(2):303-11. doi: 10.1111/j.1365-2141.1976.tb00200.x.
2
Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII.
Br J Haematol. 1976 Oct;34(2):321-30. doi: 10.1111/j.1365-2141.1976.tb00202.x.
3
Characterization of a form of bovine factor VIII which does not aggregate human platelets.
Thromb Haemost. 1981 Aug 28;46(2):479-84.
4
Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
Br J Haematol. 1976 Oct;34(2):331-40.
5
Factor VIII and human platelet aggregation. II. Characteristics of aggregation of human platelets by bovine factor VIII.
Br J Haematol. 1976 Oct;34(2):313-20. doi: 10.1111/j.1365-2141.1976.tb00201.x.
6
Preparation and properties of bovine factor VIII (antihemophilic factor).牛因子VIII(抗血友病因子)的制备与特性
Biochemistry. 1980 Feb 5;19(3):401-10. doi: 10.1021/bi00544a001.
7
The interaction of bovine factor VIII with human platelets.牛凝血因子VIII与人血小板的相互作用。
J Clin Invest. 1975 Aug;56(2):491-502. doi: 10.1172/JCI108116.
8
Polypeptide fraction from bovine factor VIII does not influence human platelet aggregation and blood coagulation.来自牛因子VIII的多肽组分不影响人血小板聚集和血液凝固。
Pharmacol Res Commun. 1988 Jan;20(1):7-12. doi: 10.1016/s0031-6989(88)80602-7.
9
The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.凝血酶对人凝血因子VIII血小板聚集活性的影响。一项关于固定化凝血酶的研究。
Thromb Haemost. 1979 Oct 31;42(3):832-7.
10
[Factor VIII-related human platelet aggregating factor (PAF) of bovine plasma].[牛血浆中与因子VIII相关的人血小板聚集因子(PAF)]
Rinsho Byori. 1979;Suppl 40:161-8.